Editorial: Predicting Hepatocellular Cancer in Clinical Practice. Authors' Reply
Alimentary Pharmacology & Therapeutics · 2026-07 · 64 (1) · 116-117
DOI: 10.1111/apt.70647 ↗Kurz gefasst
Editorial in der Zeitschrift Alimentary Pharmacology & Therapeutics, online erschienen am 25.03.2026. Verfasst von Shuaibing Ying und 2 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory for Drug Evaluation and Clinical Research of Zhejiang Province, State Key Laboratory for Diagnosis and Treatment of Infectious Disease…. Die Arbeit nennt 9 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Key Laboratory for Drug Evaluation and Clinical Research of Zhejiang Province, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Departme…
- Westlake University School of Medicine, Hangzhou, China.
ORCID-Profile: Shuaibing Ying
Zitieren
APA
Ying, S., Qiu, Y., & Lou, Y. (2026). Editorial: Predicting Hepatocellular Cancer in Clinical Practice. Authors' Reply. Alimentary Pharmacology & Therapeutics, 64(1), 116-117. https://doi.org/10.1111/apt.70647
Vancouver
Ying S, Qiu Y, Lou Y. Editorial: Predicting Hepatocellular Cancer in Clinical Practice. Authors' Reply. Alimentary Pharmacology & Therapeutics. 2026;64(1):116-117. doi:10.1111/apt.70647
BibTeX
@article{Ying2026,
author = {Ying, Shuaibing and Qiu, Yunqing and Lou, Yan},
title = {Editorial: Predicting Hepatocellular Cancer in Clinical Practice. Authors' Reply},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2026},
volume = {64},
number = {1},
pages = {116--117},
doi = {10.1111/apt.70647}
}
EUVIMED